Clinical Trials

50 enrolled

Neuroendocrine Tumors

NCT07377487 2026-03-30

INDIGO

51 enrolled

Phase NA Active not recruiting

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04804371 2026-03-23

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

40 enrolled

Neuroendocrine Tumors

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

360 enrolled

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT04104529 2026-02-05

BCB RIV

EndocrineGenitourinaryHead & NeckNET

350 enrolled

Prostatic Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors

NCT06788886 2025-12-30

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

CNSEndocrineGenitourinaryNET

147 enrolled

Brain Neoplasms, Multiple Sclerosis, Prostatic Neoplasms, Neuroendocrine Tumors

NCT06735560 2025-12-08

ELEGANCE

60 enrolled

Phase NA Active not recruiting

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

NCT02743741 2025-12-03

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

195 enrolled

Neuroendocrine Tumors

NCT03217097 2025-11-21

MGMT-NET

Phase NA Completed

116 enrolled

Neuroendocrine Tumors

NCT05017662 2025-09-04

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Phase NA Completed

20 enrolled

Neuroendocrine Tumors

NCT06908629 2025-08-26

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

EndocrineGastrointestinalNETPlasma cell

120 enrolled

Gastrointestinal Neoplasms, Multiple Myeloma, Neoplasms, Neuroendocrine Tumors

NCT07014254 2025-06-10

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Phase NA Not yet recruiting

20 enrolled

Neuroendocrine Tumors

NCT04735198 2025-05-20

TNE-IDC-COLE

100 enrolled

Phase NA Active not recruiting

Neuroendocrine Tumors, Cholecystolithiasis

NCT06204159 2025-05-20

Trinav

12 enrolled

Carcinoma, Hepatocellular, Neuroendocrine Tumors

NCT06263088 2025-05-07

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

200 enrolled